DomainSherpa is where you learn all of the secrets of the domain name industry - directly from the Sherpas.

Bitcoin pioneer and superstar Charlie Shrem joins domain name expert Andrew Rosener to discuss crypto and domain names: their intersection and overlap. Listen to them discuss crypto chain transactions and the DNS system and security tokens with domain names.

Plus, these 2 visionaries dream about the future: the digital nomad lifestyle, how domains & crypto play into a future & ideology of an all-digital, decentralized world and possible shifts in global borders!

What do successful domain name investors think when they value domain names?

In this show:
• We learn what the Sherpas bought or sold recently: CheerUp.com, WriteForBusiness.com, undisclosed CCV.COM
• An investor’s portfolio is appraised: Fungibility.org, Asap.loans, GGRK.org…
• Get your bids in soon for ArizonaHomes.com, MrProfit.com, SavePlanetEarth.com…• Plus, much more!

We’re joined by Adam Strong, Larry Fischer & Andrew Rosener.

The Internet Commerce Association (ICA), the only trade organization advocating for the rights and interests of domain name owners and related service providers, discusses its current work to stop another potential VeriSign .COM pricing increase & its current focus on much-needed UDRP reform.

Anyone invested in domain names whatsoever should be aware of the ICA’s work & understand Verisign’s no-bid contract to run the .COM registry. Consider signing the petition and getting involved!

What do successful domain name investors think when they value domain names?

In this show:
• We learn what the Sherpas bought or sold recently: Yardz.com, JLJ.com, Fishmongers.com
• An investor’s portfolio is appraised: eHop.com, GrassHero.com, Ovux.com…
• Get your bids in soon for 864.com, GlobalCare.com, Grape.net…• Plus, much more!

We’re joined by Giuseppe Graziano, Shane Cultra & Andrew Rosener.

When entrepreneur Adrian McKeown started a new online makeup business, his prior knowledge of domain values lead him to acquire category killer ccTLD Makeup.co.nz. In just 2 1/2 years, it’s grown to annual sales of 7 figures. Learn how the credibility of having the EMD category killer lead to key business opportunities. He discusses why he’s not switching from the exact match domain to a more brandable domain name, which is especially unusual in the highly branded makeup market, but he shares how his understanding of this particular niche informed his domain strategy and branding strategy.

Investors and entrepreneurs who incorporate domains into brand strategy will benefit from today’s show.

What do successful domain name investors think when they value domain names?

In this show:
• We learn what the Sherpas bought or sold recently: WOD.com, LiveVentures.com, AmericanRooster.com
• An investor’s portfolio is appraised: Isodon.com, AlcoholOffers.com, AmericaDecidez.com…
• Get your bids in soon for MedicalExam.com, DoWork.com, LuxuryGetaways.com…• Plus, much more!

We’re joined by Joe Uddeme, Shane Cultra & Andrew Rosener.

The CEO of a global organization discusses why they acquired a 2 letter .COM, ran it as a parallel brand, and are now rebranding to PX.com. Frans van Hulle calls the 2 letter the holy grail that stands on its own TWO feet. (haha)

We discuss the advantage he’s seen with a 2 letter .COM and the tangible impact in enterprise value that a 2 letter .COM brings to an organization like theirs.

What do successful domain name investors think when they value domain names?

In this show:
• We learn what the Sherpas bought or sold recently: CoinChamp.com, CallBack.net, HRE.com
• An investor’s portfolio is appraised: ImmersiveSports.com, 360Films.com, eVTOLs.com…
• Get your bids in soon for Advertising.org, Yoko.com, Drink.Beer…• Plus, much more!

We’re joined by Ammar Kubba, Mark Levine & Andrew Rosener.

Serial Entrepreneur Michael Gargiulo discusses how the EMD is contributing to the company’s ongoing success, including 8 recent offers. He & Andrew Rosener get into a heated debate about Michael’s recent Forbes article on how to value EMDs and the Rosener Equation, and Rosener makes predictions about a major shift coming to the EMD market.